UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models

Epilepsia (Copenhagen), 2008-07, Vol.49 (7), p.1213-1220

2008

Volltextzugriff (PDF)

Endogenous Serine Protease Inhibitor Modulates Epileptic Activity and Hippocampal Long-Term Potentiation

The Journal of neuroscience, 1997-06, Vol.17 (12), p.4688-4699

1997

Volltextzugriff (PDF)

A survey on the user acceptance of PV battery storage systems

Sustainability Management Forum = NachhaltigkeitsManagementForum, 2021-06, Vol.29 (2), p.161-171

2021

Volltextzugriff (PDF)

AMPA receptor antagonists: potential therapeutic applications

Recent patents on CNS drug discovery, 2006-11, Vol.1 (3), p.247

2006

Volltextzugriff (PDF)

Toxicity testing in the 21st century beyond environmental chemicals

ALTEX, alternatives to animal experimentation, 2015, Vol.32 (3), p.171-181

2015

Volltextzugriff (PDF)

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures

European journal of pharmacology, 1994-12, Vol.271 (2), p.301-308

1994

Volltextzugriff (PDF)

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

Bioorganic & medicinal chemistry letters, 2002-04, Vol.12 (7), p.1099-1102

2002

Volltextzugriff (PDF)

Redistribution of GABAB(1) Protein and Atypical GABAB Responses in GABAB(2)-Deficient Mice

The Journal of neuroscience, 2004-07, Vol.24 (27), p.6086-6097

2004

Volltextzugriff (PDF)

Specific γ-hydroxybutyrate-binding sites but loss of pharmacological effects of γ-hydroxybutyrate in GABAB(1)-deficient mice

The European journal of neuroscience, 2003-11, Vol.18 (10), p.2722-2730

2003

Volltextzugriff (PDF)

Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice

The European journal of neuroscience, 2003-11, Vol.18 (10), p.2722

2003

Volltextzugriff (PDF)

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3358-3361

2011

Volltextzugriff (PDF)

Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse

Neuropharmacology, 2013-09, Vol.72, p.66-73

2013

Volltextzugriff (PDF)

Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7

The Journal of neuroscience, 2001-11, Vol.21 (22), p.8734-8745

2001

Volltextzugriff (PDF)

Epilepsy, Hyperalgesia, Impaired Memory, and Loss of Pre- and Postsynaptic GABAB Responses in Mice Lacking GABAB(1)

Neuron (Cambridge, Mass.), 2001-07, Vol.31 (1), p.47-58

2001

Volltextzugriff (PDF)

Phosphinic Acid Analogs of GABA. 2. Selective, Orally Active GABAB Antagonists

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3313-3331

1995

Volltextzugriff (PDF)

Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders

Journal of receptors and signal transduction, 2006-01, Vol.26 (5-6), p.527-547

2006

Volltextzugriff (PDF)

N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA(glycine) antagonists

Bioorganic & medicinal chemistry letters, 1999-01, Vol.9 (2), p.249-254

1999

Volltextzugriff (PDF)

Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABA B(1) ‐deficient mice

The European journal of neuroscience, 2003-11, Vol.18 (10), p.2722-2730

2003

Volltextzugriff (PDF)

Redistribution of GABA B(1) Protein and Atypical GABA B Responses in GABA B(2) -Deficient Mice

The Journal of neuroscience, 2004-07, Vol.24 (27), p.6086-6097

2004

Volltextzugriff (PDF)

Redistribution of GABA sub(B(1)) Protein and Atypical GABA sub(B) Responses in GABA sub(B(2))-Deficient Mice

The Journal of neuroscience, 2004-07, Vol.24 (27), p.6086-6097

2004

Volltextzugriff (PDF)

Comparative in vivo and in vitro studies with the potent GABA B receptor antagonist, CGP 56999A

European journal of pharmacology, 1997, Vol.333 (2), p.135-142

1997

Volltextzugriff (PDF)

5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists

Bioorganic & medicinal chemistry letters, 1998-03, Vol.8 (5), p.493-498

1998

Volltextzugriff (PDF)

5-aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists

Bioorganic & medicinal chemistry letters, 1998-01, Vol.8 (1), p.65-70

1998

Volltextzugriff (PDF)

Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors

Bioorganic & medicinal chemistry letters, 2000-01, Vol.10 (1), p.75-78

2000

Volltextzugriff (PDF)

Relevance of kindling and related processes to human epileptogenesis

Progress in neuro-psychopharmacology & biological psychiatry, 1987, Vol.11 (4), p.505-525

Schmutz, Markus

1987

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(30)
Animals
(25)
Mice
(18)
Humans
(13)
Biological And Medical Sciences
(12)
Physical Sciences
(12)
Medical Sciences
(11)
Pharmacology. Drug Treatments
(10)
Chemistry
(9)
Neuropharmacology
(9)
Pharmacology & Pharmacy
(9)
Rats
(9)
Neurosciences & Neurology
(8)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(7)
Chemistry, Medicinal
(7)
Male
(7)
Technology
(7)
Anticonvulsants - Pharmacology
(6)
Chemistry, Organic
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models

Endogenous Serine Protease Inhibitor Modulates Epileptic Activity and Hippocampal Long-Term Potentiation

A survey on the user acceptance of PV battery storage systems

AMPA receptor antagonists: potential therapeutic applications

Toxicity testing in the 21st century beyond environmental chemicals

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

Redistribution of GABAB(1) Protein and Atypical GABAB Responses in GABAB(2)-Deficient Mice

Specific γ-hydroxybutyrate-binding sites but loss of pharmacological effects of γ-hydroxybutyrate in GABAB(1)-deficient mice

Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse

Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7

Epilepsy, Hyperalgesia, Impaired Memory, and Loss of Pre- and Postsynaptic GABAB Responses in Mice Lacking GABAB(1)

Phosphinic Acid Analogs of GABA. 2. Selective, Orally Active GABAB Antagonists

Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders

N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA(glycine) antagonists

Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABA B(1) ‐deficient mice

Redistribution of GABA B(1) Protein and Atypical GABA B Responses in GABA B(2) -Deficient Mice

Redistribution of GABA sub(B(1)) Protein and Atypical GABA sub(B) Responses in GABA sub(B(2))-Deficient Mice

Comparative in vivo and in vitro studies with the potent GABA B receptor antagonist, CGP 56999A

5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists

5-aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists

Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors

Relevance of kindling and related processes to human epileptogenesis

Suchergebnisse filtern